Histone deacetylase 1 is required for transforming growth factor-β1-induced epithelial-mesenchymal transition

International Journal of Biochemistry and Cell Biology

Volumn 42, Issue 9, 2010, Pages 1489-1497

  Lei, Weiwei ^a   Zhang, Kehua ^a   Pan, Xinchao ^a   Hu, Ying ^a   Wang, Dongmei ^a   Yuan, Xinwang ^a   Shu, Guangwen ^a   Song, Jianguo ^a  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

E cadherin; EMT; HDAC; Hepatocytes; TGF ; ZO 1

Indexed keywords

HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; MESSENGER RNA; PROTEIN ZO1; TRANSFORMING GROWTH FACTOR BETA1; UVOMORULIN; CALCIUM; MITOGEN ACTIVATED PROTEIN KINASE P38;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; LIVER CELL; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RNA INTERFERENCE; TRANSCRIPTION REGULATION; APOPTOSIS; CELL DIFFERENTIATION; CELL SURVIVAL; CYTOLOGY; DRUG EFFECTS; EPITHELIUM CELL; HUMAN; MESODERM; METABOLISM; MITOCHONDRIAL MEMBRANE POTENTIAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; U937 CELL LINE; WESTERN BLOTTING;

MURINAE;

APOPTOSIS; BLOTTING, WESTERN; CALCIUM; CELL DIFFERENTIATION; CELL SURVIVAL; EPITHELIAL CELLS; HISTONE DEACETYLASE 1; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MESODERM; P38 MITOGEN-ACTIVATED PROTEIN KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRANSFORMING GROWTH FACTOR BETA1; U937 CELLS;

EID: 77955094541     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2010.05.006     Document Type: Article

References (51)

1. Armeanua S., Pathila A., Venturellia S., Mascagnib P., Weissc T.S., Göttlicherd M., et al. Apoptosis on hepatoma cells but not on primary hepatocytes by histone deacetylase inhibitors valproate and ITF2357. J Hepatol 2005, 42:210-217.
2. Batlle E., Sancho E., Franci C., Dominguez D., Monfar M., Baulida J., et al. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2000, 2:84-89.
3. Bolden J.E., Peart M.J., Johnstone R.W. Anticancer activities of histone deacetylase inhibitors. Nat Rev Drug Discov 2006, 5:769-784.
4. Cano A., Perez-Moreno M.A., Rodrigo I., Locascio A., Blanco M.J., del Barrio M.G., et al. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2000, 2:76-83.
5. Dumont N., Wilson M.B., Crawford Y.G., Reynolds P.A., Sigaroudinia M., Tlsty T.D. Sustained induction of epithelial to mesenchymal transition activates DNA methylation of genes silenced in basal-like breast cancers. Proc Natl Acad Sci USA 2008, 105:14867-14872.
6. Farooqa M., Sulochanaa K.N., Pana X., Toa J., Shenga D., Gonga Z., et al. Histone deacetylase 3 (hdac3) is specifically required for liver development in zebrafish. Dev Biol 2008, 317:336-353.
7. Fransvea E., Angelotti U., Antonaci S., Giannelli G. Blocking transforming growth factor-beta up-regulates E-cadherin and reduces migration and invasion of hepatocellular carcinoma cells. Hepatology 2008, 47:1557-1566.
8. Gottardi C.J., Arpin M., Fanning A.S., Louvard D. The junction-associated protein, zonula occludens-1, localizes to the nucleus before the maturation and during the remodeling of cell-cell contacts. Proc Natl Acad Sci USA 1996, 93:10779-10784.
9. Grozinger C.M., Hassig C.A., Schreiber S.L. Three proteins define a class of human histone deacetylases related to yeast Hda1p. Proc Natl Acad Sci USA 1999, 96:4868-4873.
10. Haberland M., Montgomery R.L., Olson E.N. The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat Rev Genet 2009, 10:32-42.
11. Hassig C.A., Fleischer T.C., Billin A.N., Schreiber S.L., Ayer D.E. Histone deacetylase activity is required for full transcriptional repression by mSin3A. Cell 1997, 89:341-347.
12. Hu E., Dul E., Sung C.M., Chen Z., Kirkpatrick R., Zhang G.-F., et al. Identification of Novel Isoform-Selective Inhibitors within Class I Histone Deacetylases. J Pharmacol Exp Ther 2003, 307:720-728.
13. Iredale J.P. Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest 2007, 117:539-548.
14. Janda E., Nevolo M., Lehmann K., Downward J., Beug H., Grieco M. Raf plus TGFbeta-dependent EMT is initiated by endocytosis and lysosomal degradation of E-cadherin. Oncogene 2006, 25:7117-7130.
15. Kato T., Shimono Y., Hasegawa M., Jijiwa M., Enomoto A., Asai N., et al. Characterization of the HDAC1 complex that regulates the sensitivity of cancer cells to oxidative stress. Cancer Res 2009, 69:3597-3604.
16. Lagger G., O'Carroll D., Rembold M., Khier H., Tischler J., Weitzer G., et al. Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression. EMBO J 2002, 21:2672-2681.
17. Li X., Yin S., Meng Y., Sakr W., Sheng S. Endogenous inhibition of histone deacetylase 1 by tumor-suppressive maspin. Cancer Res 2006, 66:9323-9329.
18. Liu F., Levin M.D., Petrenko N.B., Lu M.M., Wang T., Yuan L.J., et al. Histone-deacetylase inhibition reverses atrial arrhythmia inducibility and fibrosis in cardiac hypertrophy independent of angiotensin. J Mol Cell Cardiol 2008, 45:715-723.
19. Liu Y.N., Liu Y., Lee H.J., Hsu Y.H., Chen J.H. Activated androgen receptor downregulates E-cadherin gene expression and promotes tumor metastasis. Mol Cell Biol 2008, 28:7096-7108.
20. Lu Y.S., Kashida Y., Kulp S.K., Wang Y.C., Wang D., Hung J.H., et al. Efficacy of a novel histone deacetylase inhibitor in murine models of hepatocellular carcinoma. Hepatology 2007, 46:1119-1130.
21. Marumo T., Hishikawa K., Yoshikawa M., Hirahashi J., Kawachi S., Fujita T. Histone deacetylase modulates the pro-inflammatory and fibrotic changes in tubulointerstitial injury. Am J Physiol Renal Physiol 2009.
22. Miura K., Taura K., Kodama Y., Schnabl B., Brenner D.A. Hepatitis C virus-induced oxidative stress suppresses hepcidin expression through increased histone deacetylase activity. Hepatology 2008, 48:1420-1429.
23. Niki T., Rombouts K., Bleser P.D., Smet K.D., Rogiers V., Schuppan D., et al. A histone deacetylase inhibitor, trichostatin A, suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture. Hepatology 1999, 29:858-867.
24. Nitta T., Kim J.S., Mohuczy D., Behrns K.E. Murine cirrhosis induces hepatocyte epithelial mesenchymal transition and alterations in survival signaling pathways. Hepatology 2008, 48:909-919.
25. Noel E.S., Casal-Sueiro A., Busch-Nentwich E., Verkade H., Dong P.D., Stemple D.L., et al. Organ-specific requirements for Hdac1 in liver and pancreas formation. Dev Biol 2008, 322:237-250.
26. Oh Y.M., Kwon Y.E., Kim J.M., Bae S.J., Lee B.K., Yoo S.J., et al. Chfr is linked to tumour metastasis through the downregulation of HDAC1. Nat Cell Biol 2009, 11:295-302.
27. Pagan R., Sanchez A., Martin I., Llobera M., Fabregat I., Vilaro S. Effects of growth and differentiation factors on the epithelial-mesenchymal transition in cultured neonatal rat hepatocytes. J Hepatol 1999, 31:895-904.
28. Pan X., Wang X., Lei W., Min L., Yang Y., Wang X., et al. Nitric oxide suppresses transforming growth factor-beta1-induced epithelial-to-mesenchymal transition and apoptosis in mouse hepatocytes. Hepatology 2009, 50:1577-1587.
29. Peinado H., Ballestar E., Esteller M., Cano A. Snail Mediates E-Cadherin Repression by the Recruitment of the Sin3A/Histone Deacetylase 1 (HDAC1)/HDAC2 Complex. Mol Cell Biol 2004, 24:306-319.
30. Peinado H., Olmeda D., Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype. Nat Rev Cancer 2007, 7(6):415-428.
31. Reichert M., Müller T., Hunziker W. The PDZ domains of zonula occludens-1 induce an epithelial to mesenchymal transition of Madin-Darby canine kidney I cells. Evidence for a role of beta-catenin/Tcf/Lef signalling. J Biol Chem 2000, 275:9492-9500.
32. Rikimaru T., Taketomi A., Yamashita Y., Shirabe K., Hamatsu T., Shimada M., et al. Clinical significance of histone deacetylase 1 expression in patients with hepatocellular carcinoma. Oncology 2007, 72:69-74.
33. Rombouts K., Niki T., Greenwel P., Vandermonde A., Wielant A., Hellemans K., et al. Trichostatin A, a histone deacetylase inhibitor, suppresses collagen synthesis and prevents TGF-beta(1)-induced fibrogenesis in skin fibroblasts. Exp Cell Res 2002, 278:184-197.
34. Senese S., Zaragoza K., Minardi S., Muradore I., Ronzoni S., Passafaro A., et al. Role for histone deacetylase 1 in human tumor cell proliferation. Mol Cell Biol 2007, 27:4784-4795.
35. Shan B., Yao T.P., Nguyen H.T., Zhuo Y., Levy D.R., Klingsberg R.C., et al. Requirement of HDAC6 for transforming growth factor-beta1-induced epithelial-mesenchymal transition. J Biol Chem 2008, 283:21065-21073.
36. Thiery J.P., Acloque H., Huang R.Y., Nieto M.A. Epithelial-mesenchymal transitions in development and disease. Cell 2009, 139:871-890.
37. von Burstin J., Eser S., Paul M.C., Seidler B., Brandl M., Messer M., et al. E-cadherin regulates metastasis of pancreatic cancer in vivo and is suppressed by a SNAIL/HDAC1/HDAC2 repressor complex. Gastroenterology 2009, 137:361-371.
38. Wang J.C., Chen C., Dumlao T., Naik S., Chang T., Xiao Y.Y., et al. Enhanced histone deacetylase enzyme activity in primary myelofibrosis. Leuk Lymphoma 2008, 49:2321-2327.
39. Wang S., Yan-Neale Y., Fischer D., Zeremski M., Cai R., Zhu J., et al. Histone deacetylase 1 represses the small GTPase RhoB expression in human nonsmall lung carcinoma cell line. Oncogene 2003, 22:6204-6213.
40. Willis B.C., Borok Z. TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease. Am J Physiol Lung Cell Mol Physiol 2007, 293:L525-L534.
41. Yamaguchi H., Yi Ding J.F.L., Zhang M., Pal A., Bornmann W., Yan D.H., et al. Interferon-inducible protein IFIXalpha inhibits cell invasion by upregulating the metastasis suppressor maspin. Mol Carcinog 2008, 47:739-743.
42. Yamashita Y., Shimada M., Harimoto N., Rikimaru T., Shirabe K., Tanaka S., et al. Histone deacetylase inhibitor trichostatin A induces cell-cycle arrest/apoptosis and hepatocyte differentiation in human hepatoma cells. Int J Cancer 2003, 103:572-576.
43. Yang J., Weinberg R.A. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 2008, 14:818-829.
44. Yang Y., Pan X., Lei W., Wang J., Shi J., Li F., et al. Regulation of transforming growth factor-beta 1-induced apoptosis and epithelial-to-mesenchymal transition by protein kinase A and signal transducers and activators of transcription 3. Cancer Res 2006, 66:8617-8624.
45. Yang Y., Pan X., Lei W., Wang J., Song J. Transforming growth factor-beta1 induces epithelial-to-mesenchymal transition and apoptosis via a cell cycle-dependent mechanism. Oncogene 2006, 25:7235-7244.
46. Yoo Y.G., Na T.Y., Seo H.W., Seong J.K., Park C.K., Shin Y.K., et al. Hepatitis B virus X protein induces the expression of MTA1 and HDAC1, which enhances hypoxia signaling in hepatocellular carcinoma cells. Oncogene 2008, 27:3405-3413.
47. Yoshikawa M., Hishikawa K., Marumo T., Fujita T. Inhibition of histone deacetylase activity suppresses epithelial-to-mesenchymal transition induced by TGF-beta1 in human renal epithelial cells. J Am Soc Nephrol 2007, 18:58-65.
48. Zeisberg M., Kalluri R. The role of epithelial-to-mesenchymal transition in renal fibrosis. J Mol Med 2004, 82:175-181.
49. Zeisberg M., Yang C., Martino M., Duncan M.B., Rieder F., Tanjore H., et al. Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J Biol Chem 2007, 282:23337-23347.
50. Zhang K.H., Tian H.Y., Gao X., Lei W.W., Hu Y., Wang D.M., et al. Ferritin heavy chain-mediated iron homeostasis and subsequent increased reactive oxygen species production are essential for epithelial-mesenchymal transition. Cancer Res 2009, 69:5340-5348.
51. Zhou Y., Wang D., Li F., Shi J., Song J. Different roles of protein kinase C-betaI and -delta in the regulation of adipocyte differentiation. Int J Biochem Cell Biol 2006, 38:2151-2163.